(Q90854014)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

title

Cerebrospinal fluid from Alzheimer patients affects cell-mediated nerve growth factor production and cell survival in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Maria Eriksdotter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Manuel Navarro-Oviedo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Lars Wahlberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Bengt Linderoth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Lars O Tjernberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

Homira Behbahani

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

publication date

6 August 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

16 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

volume

371

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

page(s)

175-184

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease

16 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

NGF treatment promotes development of basal forebrain tissue grafts in the anterior chamber of the eye.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Nerve growth factor in treatment and pathogenesis of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Cholinergic system during the progression of Alzheimer's disease: therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Development of a non invasive NGF-based therapy for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in the mouse with ibotenic acid-induced cognitive dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Cell encapsulation: technical and clinical advances

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Encapsulated cell biodelivery of nerve growth factor to the Basal forebrain in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Brain changes in Alzheimer's disease patients with implanted encapsulated cells releasing nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Göttingen minipig basal forebrain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Flow cytometry as a method for studying effects of stressors on primary rat neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine,

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Analysis of microdissected neurons by 18O mass spectrometry reveals altered protein expression in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Automated comparative proteomics based on multiplex tandem mass spectrometry and stable isotope labeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

2016 update of the PRIDE database and its related tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Mitochondria, oxidative stress and cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Alzheimer's disease: An overview of amyloid beta dependent pathogenesis and its therapeutic implications along with in silico approaches emphasizing the role of natural products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Cell density-dependent inhibition of epidermal growth factor receptor signaling by p38alpha mitogen-activated protein kinase via Sprouty2 downregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Transfection techniques for neuronal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Cerebrospinal Fluid Alzheimer Markers in Depressed Elderly Subjects with and without Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Acute and subacute IL-1β administrations differentially modulate neuroimmune and neurotrophic systems: possible implications for neuroprotection and neurodegeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Mast cells and tissue reaction to intraperitoneally implanted polymer capsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Anti-inflammatory polymeric coatings for implantable biomaterials and devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Dexamethasone-coated neural probes elicit attenuated inflammatory response and neuronal loss compared to uncoated neural probes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Inflammatory mechanisms in Alzheimer's disease: implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Alpha 1-antitrypsin in cerebrospinal fluid of patients with neurologic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Clusterin Binds to Aβ1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Clusterin inhibits apoptosis by interacting with activated Bax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Clusterin induces matrix metalloproteinase-9 expression via ERK1/2 and PI3K/Akt/NF-κB pathways in monocytes/macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Clusterin in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

Activation of complement and contact system in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2018.08.007

10.1016/J.YEXCR.2018.08.007

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json

16 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30092220%20AND%20SRC:MED&resulttype=core&format=json